Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative dexmedetomidine for renal protection after EVAR in Stanford type B aortic dissection
ChiCTR-IPR-15006372Phase 4Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in aortic dissection (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: acute kidney injury. Started Dec 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
aortic dissection
Beyond the preview
Go deeper on ChiCTR-IPR-15006372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006372.